| Dolores M Figueroa, MD | |
|
301 S Fair Oaks Ave Ste 405, Pasadena, CA 91105-2562 | |
| (626) 440-7325 | |
| (626) 440-7310 |
| Full Name | Dolores M Figueroa |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 301 S Fair Oaks Ave Ste 405, Pasadena, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033287701 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A72888 (California) | Primary |
| Entity Name | Healthcare Partners Affiliates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659312593 PECOS PAC ID: 7315842002 Enrollment ID: O20031204001258 |
News Archive
A study of teens diagnosed with the vaping-linked respiratory disease EVALI revealed that most also had gastrointestinal symptoms and a history of psychosocial factors, including substance abuse, UT Southwestern researchers found in one of the first clinical reviews of its kind.
People who are easily distressed and have more negative emotions are more likely to develop memory problems than more easygoing people, according to a study published in the June 12, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people, according to research published today in Cancer Research.
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
An upcoming clinical trial at Children's National Hospital will harness cardiopulmonary bypass as a delivery mechanism for a novel intervention designed to stimulate brain growth and repair in children who undergo cardiac surgery for congenital heart disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dolores M Figueroa, MD 301 S Fair Oaks Ave Ste 405, Pasadena, CA 91105-2562 Ph: (626) 440-7325 | Dolores M Figueroa, MD 301 S Fair Oaks Ave Ste 405, Pasadena, CA 91105-2562 Ph: (626) 440-7325 |
News Archive
A study of teens diagnosed with the vaping-linked respiratory disease EVALI revealed that most also had gastrointestinal symptoms and a history of psychosocial factors, including substance abuse, UT Southwestern researchers found in one of the first clinical reviews of its kind.
People who are easily distressed and have more negative emotions are more likely to develop memory problems than more easygoing people, according to a study published in the June 12, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people, according to research published today in Cancer Research.
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
An upcoming clinical trial at Children's National Hospital will harness cardiopulmonary bypass as a delivery mechanism for a novel intervention designed to stimulate brain growth and repair in children who undergo cardiac surgery for congenital heart disease.
› Verified 7 days ago
Ms. Kimberly Anne Shriner, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 Alessandro Pl, Suite 360, Pasadena, CA 91105 Phone: 626-793-6133 Fax: 626-793-6135 | |
Praneet Kalkat, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 960 E Green St Ste 105, Pasadena, CA 91106 Phone: 626-304-0782 Fax: 626-310-0552 | |
Gargi H Upadhyaya, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1121 Arden Rd, Pasadena, CA 91106 Phone: 626-256-4673 | |
Lu Jiao, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 S Fair Oaks Ave, Suite 300, Pasadena, CA 91105 Phone: 626-795-7556 | |
Kristin J Karlyn, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1044 S Fair Oaks Ave Ste 101, Pasadena, CA 91105 Phone: 626-734-7870 Fax: 626-593-6550 | |
Dr. Glenn David Littenberg, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 630 S Raymond Ave, Suite 240, Pasadena, CA 91105 Phone: 626-449-9920 Fax: 626-578-7366 | |
Dr. Robert E Ladines, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1515 N Fair Oaks Ave, Pasadena, CA 91103 Phone: 626-798-1111 Fax: 626-345-1901 |